Where does Alfa Biogene International B.V. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Alfa Biogene International B.V. ranks #44,576 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Alfa Biogene International B.V. hold?

Alfa Biogene International B.V. holds 5 US utility patents granted between 2015 and 2021, spanning 6 technology areas.

What is Alfa Biogene International B.V.'s Innovation Score?

Alfa Biogene International B.V. has an Innovation Score of 24.0 out of 100 (13th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Alfa Biogene International B.V. focus on?

Alfa Biogene International B.V.'s top technology area is C07K (Peptides) with 4 patents. Grants appear in 6 CPC subclasses total.

Is Alfa Biogene International B.V.'s patent grant rate increasing or decreasing?

Alfa Biogene International B.V.'s recent grant velocity is -75% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Alfa Biogene International B.V.'s patents?

Alfa Biogene International B.V.'s patents average 15.2 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Alfa Biogene International B.V. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Alfa Biogene International B.V.

USPTO PatentsView assignee record - 5 granted patents across 6 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Alfa ranks #44,576 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 6 technology areas.

#44,576
of 49,997 US assignees by volume: 13th percentile
by Innovation Score (24.0/100): 15.2
avg claims per patent: -75%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R44576 · Foreign Corporation #44,576 · 5 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
LOWER-Q #44,576/49,997
PHOTO-FINISH Alcobra
CPC-NARROW C07K · 6 areas
INNOV-THIN 24.0/100
CLAIMS-RICH 15.2 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -75% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Alcobra Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Alfa Biogene… · this assignee

24
3D Lighting… · lowest

7

What this shows Alfa's Innovation Score is 24.0/100 (13th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where Alfa's grants concentrate

Alfa Biogene International B.V. is a focused PatentsView assignee: 6 CPC subclasses with 80% of grants classified under C07K (Peptides). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2018. By volume, Alfa sits between Alcobra Ltd. and Alida Biosciences Inc..

Alcobra

5
Aleco Container

5
Alencon Acquisiti…

5
Alexander Andrew

5
Alfelder Kunststo…

5
Alger Alternative…

5
Alibaba Cloud Com…

5
Alida Biosciences

5
Alfa Biogene Inte… ◀

5

What this shows Alfa holds 5 patents at rank #44,809, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Alfa

By rank, the assignees closest to #44,809 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Alfa's primary technology class.

Alfa's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

24 13th percentile higher than 13% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Alfa Biogene International B.V. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	60.0%
2018	1	20.0%
2021	1	20.0%

Which technologies does Alfa Biogene International B.V. patent most?

C07K - Peptides 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 4

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 4

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 3

Y02A - Technologies FOR Adaptation TO Climate Change 2

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

Top 6 of 6 technology areas

Where it ranks

Overall rank by patents

#44,576

of 49,997 tracked assignees

Innovation Score

24.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Alfa Biogene International B.V.'s patent record in context - here's where to go next.

Alfa Biogene International B.V.'s lead technology class is C07K (Peptides), 80% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #44,576 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Alfa Biogene International B.V. against Alcobra Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.